Japan
CRO Services in Japan
While Linical has grown across the globe to cover the world’s top clinical development regions (North America, Europe, and Asia-Pacific), our company originated in Japan nearly two decades ago. Founded by leaders in drug development from a Japanese pharmaceutical company, Linical was created with a vision of advancing clinical research for new and unmet medical needs. Linical is publicly traded on the Tokyo Stock Exchange, providing financial stability with a focus on quality delivery for our clients and the patients we help improve therapies for.
There are many benefits to conducting clinical trials in Japan, and Japan continues be the third largest pharmaceutical market in the world. Japan remains one of the most important regions for both local and global biopharmaceutical companies, with continued demands for innovative therapies. Through partnering with a contract research organization (CRO) in Japan, pharmaceutical and biotechnology companies can achieve more successful outcomes.
Choosing an Experienced Japanese CRO
When designing and executing clinical trials in Japan, it is vital to work with an experienced Japanese CRO. The right Japanese CRO partner will have actual staff located in Japan, providing the necessary guidance and network to optimize timing and costs of Japanese clinical trials. Clients should look for a CRO with a proven track record of conducting clinical trials in Japan, providing the experience, resources, and know-how every step of the way. They will be knowledgeable about the nuances of the clinical development landscape in Japan, adding value in a multitude of areas such as:
Protocol development and study design considerations
Patient population dynamics and a robust recruitment strategy for Japanese patients
Deep knowledge of local regulations and PMDA requirements
Relationships with medical centers and physicians in Japan
Effective timeline and cost management strategies
Focus on quality through the project
Smooth communication and navigation of cultural considerations
Navigating Clinical Trials in Japan
Linical’s team of local experts possess deep, local regulatory knowledge and excellent relationship with sites, KOLs, and PIs, providing guidance and the best solutions to avoid obstacles and ensure the success of your clinical studies in Japan.
Comprehensive Japan CRO Services
Linical is a full-service clinical development partner, with capabilities spanning all key areas of clinical development, from planning and protocol development, to regulatory and compliance, to medical and clinical operations. We provide comprehensive, integrated CRO services in Japan from early phase through late phase development, including drug development strategy and clinical trial management services. Our CRO services in Japan include:
End-to-end Support for Clinical Development in Japan
Linical offers support to biotech and pharma companies from the earliest phase of development, not only proving full-service drug development services but also helping companies interested in entering the Japanese market that may be unfamiliar with its regulations. We help organizations with market access, development & regulatory strategy, PMDA consultation, and can aid companies in the process of looking for partners or licensing. Linical is your gateway to the Japanese clinical development market.
The Right-Choice CRO
Successful clinical trials start with Linical.
Don’t let the complex clinical development journey hold you back. With Linical, you can overcome obstacles, save valuable time and money, and reach your goals.
01 Request a proposal
We start by listening to your needs and understanding your goals to ensure we’re the right CRO for you.
02 Get a plan for success
We propose solutions that proactively tackle obstacles, optimize your trial design, and position you for success every step of the way.
03 Execute with confidence
We’ll guide you through each phase of the process, offering personalized support and a full range of services to help you achieve a successful trial. We are not a “one size fits all” CRO.